MTR4 anticorps (Middle Region)
Aperçu rapide pour MTR4 anticorps (Middle Region) (ABIN453828)
Antigène
Voir toutes MTR4 (SKIV2L2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- This antibody reacts to SKIV2L2.
-
Purification
- Affinity chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide selected from the Center region of human SKIV2L2
-
-
-
-
Indications d'application
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MTR4 (SKIV2L2) (Superkiller Viralicidic Activity 2-Like 2 (SKIV2L2))
-
Autre désignation
- SKIV2L2
-
Sujet
- SKIV2L2 may be involved in pre-mRNA splicing.Synonyms: ATP-dependent helicase SKIV2L2, Dob1, KIAA0052, Mtr4, Superkiller viralicidic activity 2-like 2
-
ID gène
- 23517
-
NCBI Accession
- NP_056175
-
UniProt
- P42285
Antigène
-